Skygomet-PG2 Tablet ER
Marketer
Bhesaja Remedies Pvt Ltd
Salt Composition
Glimepiride (2mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Skygomet-PG2 Tablet ER
Glucovance XR is a dual-action medication formulated to manage blood glucose concentrations. This medication, used in conjunction with a balanced diet and regular exercise, enhances glycemic control in adult patients with type 2 diabetes. It facilitates improved insulin utilization, resulting in decreased blood sugar. Dosage and treatment duration for Glucovance XR should strictly adhere to your physician's instructions. Administer the medication with food to minimize gastrointestinal discomfort. For missed doses, take the medication as soon as remembered, unless the next dose is imminent; in such cases, omit the missed dose and resume the regular schedule. Never double the dose. An overdose can cause dangerously low blood sugar (hypoglycemia). Concurrent use with other antidiabetic agents, alcohol consumption, or skipped meals may increase the risk of hypoglycemia. Regular blood glucose monitoring is crucial while using this medication. Common adverse effects may include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Prior to commencing treatment, inform your doctor about any pre-existing kidney, liver, or heart conditions. Pregnant or lactating women should consult their physician before use. Kidney function tests will be evaluated by your doctor before initiating therapy. Limit alcohol consumption as it may heighten the risk of side effects.
Primary Ingredients of Skygomet-PG2 Tablet ER
No text provided. Please provide the text you want me to rephrase.
Uses of Skygomet-PG2 Tablet ER
Managing Type 2 Diabetes
Major Benefits of Skygomet-PG2 Tablet ER:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Skygomet-PG2 Extended-Release Tablets should be administered with a meal.
Common Side effects of Skygomet-PG2 Tablet ER:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Skygomet-PG2 Tablet ER:
Follow your doctor's instructions precisely regarding dosage and treatment length for Skygomet-PG2 Tablet ER. Ingest the tablet whole; avoid chewing, crushing, or breaking it. Administer this medication with a meal.
How Skygomet-PG2 Tablet ER works:
Skygomet-PG2 Extended-Release tablets combine glimepiride, metformin, and pioglitazone—three distinct antidiabetic agents. This triple-drug approach offers enhanced blood sugar management when single or dual medications prove insufficient. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion, reducing blood glucose levels. Metformin, a biguanide, acts through multiple pathways: decreasing hepatic glucose production, slowing intestinal glucose absorption, and improving insulin responsiveness. Finally, pioglitazone, a thiazolidinedione, augments insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Combining Skygomet-PG2 Tablet ER and alcohol is inadvisable due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
The extended-release Skygomet-PG2 Tablet may pose pregnancy risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the treatment's advantages against possible dangers prior to prescription. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Skygomet-PG2 tablets are likely unsafe for breastfeeding mothers. Available human data indicates potential transfer to breast milk, posing a risk to the infant.
DrivingCAUTION
Impaired driving is possible with both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar fluctuations.
KidneyCAUTION
Patients with impaired kidney function should exercise caution when using Skygomet-PG2 Tablet ER, as dose modification may be necessary. Severe kidney disease contraindicates the use of Skygomet-PG2 Tablet ER. Medical supervision, including regular kidney function assessments, is recommended during treatment.
LiverCAUTION
Patients with hepatic impairment should use Skygomet-PG2 Tablet ER cautiously, potentially requiring dosage modification. Consultation with a physician is advised. Skygomet-PG2 Tablet ER is contraindicated in individuals with severe liver disease.
What if you forget to take Skygomet-PG2 Tablet ER :
Should you forget a Skygomet-PG2 Tablet ER dose, take it promptly. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Skygomet-PG2 Tablet ER
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |



